Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

Autonomize AI Strengthens Leadership Team with Key Appointments

April 30, 2024 at 08:00 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Brings industry veterans in AI and healthcare to support fast growth

Autonomize AI, a pioneer in AI-driven healthcare solutions, announced two key appointments to its leadership team: Jennifer Kloke, PhD, as Vice President of Artificial Intelligence (AI), and Jeffrey Eyestone as Vice President of Business Development.

Dr. Jennifer Kloke steps into her role as an accomplished leader in AI product innovation. Her tenure at LinkedIn saw the creation of groundbreaking features like the LLM-based 'Enhance Your Profile' and AI-generated InMail, significantly boosting user engagement and revenue. Previously, as VP of Product and CTO at Ayasdi, she was instrumental in advancing their healthcare AI platform, notably through the development of Ayasdi CARE, which revolutionized care pathways in hospitals. Jennifer’s expertise in integrating AI with user-centric product design is key in driving AI adoption in healthcare for Autonomize.

Jeffrey Eyestone brings over 25 years of experience in Healthcare AI and Information Technology. His career has been marked by significant contributions to the development of AI solutions for major healthcare entities such as United Healthcare and CVS Health. Jeffrey’s expertise encompasses a broad spectrum of AI applications, from care management to sales acceleration, benefiting top-tier payers, providers, and life sciences organizations. His prior roles at prestigious firms like J.P. Morgan and Wells Fargo, coupled with entrepreneurial success, have equipped him well for his new role. Jeffrey holds an MBA from the London Business School and a bachelor’s degree from Lafayette College.

Ganesh Padmanabhan, CEO of Autonomize AI, expressed his enthusiasm about the new additions: “We are thrilled to welcome Jennifer and Jeffrey to our team. Their vast experience and innovative vision will be crucial as we continue to expand the possibilities of AI in healthcare.”

These appointments come at a pivotal time for Autonomize AI, as it gears up for significant growth and innovation, reinforcing its position as a leader in healthcare AI.

About Autonomize AI

Autonomize’s AI copilots organize, contextualize and summarize unstructured data to reduce the administrative burden for healthcare knowledge workers to make data-driven decisions and improve patient outcomes. Autonomize AI is a founding member of CancerX, the US President’s Cancer Moonshot initiative. Our customers include Top 20 pharma, F100 Payors and life sciences companies.